Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression | Zendy

Ella Daly | Zendy; Madhukar H. Trivedi | Zendy; Adam Janik | Zendy; Honglan Li | Zendy; Yun Zhang | Zendy; Xiang Li | Zendy; Rosanne Lane | Zendy; Pilar Lim | Zendy; A. Duca | Zendy; David Hough | Zendy; Michael E. Thase | Zendy; John Zajecka | Zendy; Andrew Winokur | Zendy; Ilona Divacka | Zendy; Andrea Fagiolini | Zendy; Wiesław Jerzy Cubała | Zendy; István Bitter | Zendy; Pierre Blier | Zendy; Richard C. Shelton | Zendy; Patricio Molero | Zendy; Husseini K. Manji | Zendy; Wayne C. Drevets | Zendy; Jaskaran Singh | Zendy

Open Access

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

Author(s) -

Ella Daly,

Madhukar H. Trivedi,

Adam Janik,

Honglan Li,

Yun Zhang,

Xiang Li,

Rosanne Lane,

Pilar Lim,

A. Duca,

David Hough,

Michael E. Thase,

John Zajecka,

Andrew Winokur,

Ilona Divacka,

Andrea Fagiolini,

Wiesław Jerzy Cubała,

István Bitter,

Pierre Blier,

Richard C. Shelton,

Patricio Molero,

Husseini K. Manji,

Wayne C. Drevets,

Jaskaran Singh

Publication year - 2019

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2019.1189

Subject(s) - nasal spray , medicine , placebo , antidepressant , treatment resistant depression , randomized controlled trial , anesthesia , depression (economics) , nasal administration , pharmacology , alternative medicine , macroeconomics , pathology , hippocampus , economics

Controlled studies have shown short-term efficacy of esketamine for treatment-resistant depression (TRD), but long-term effects remain to be established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research